CS logo
small CS logo
London Regional Cancer Program

London, Ontario, Canada
Cancer treatment center in London, Ontario
London, ON N6A 5W9

About London Regional Cancer Program


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
NCIC Clinical Trials Group
64
Radiation Therapy Oncology Group
59
Lawson Health Research Institute
41
National Cancer Institute (NCI)
40
Canadian Cancer Trials Group
34
Ontario Clinical Oncology Group (OCOG)
26
Alliance for Clinical Trials in Oncology
21
University Health Network, Toronto
17
Hoffmann-La Roche
12
Pfizer
11
European Organisation for Research and Treatment of Cancer - EORTC
10
Total Rows: 70

Clinical Trials at London Regional Cancer Program


During the past decade, London Regional Cancer Program conducted 124 clinical trials. In the 10-year time frame, 124 clinical trials started and 116 clinical trials were completed, i.e. on average, 93.5% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 47 clinical trials were completed. i.e. 123.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1616252514141515991313111144118811112727121288111116167755Started TrialsCompleted Trails2015201620172018201920202021202220230102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tamoxifen in Treating Women With High-Risk Breast Cancer
1993-07-20
2011-01-11
Completed
672
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
1994-02-01
Completed
200

Rows per page:

1–100 of 431

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "London Regional Cancer Program" #1 sponsor was "NCIC Clinical Trials Group" with 64 trials, followed by "Radiation Therapy Oncology Group" with 59 trials sponsored, "Lawson Health Research Institute" with 41 trials sponsored, "National Cancer Institute (NCI)" with 40 trials sponsored and "Canadian Cancer Trials Group" with 40 trials sponsored. Other sponsors include 188 different institutions and companies that sponsored additional 70 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "London Regional Cancer Program" #1 collaborator was "National Cancer Institute (NCI)" with 137 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "NCIC Clinical Trials Group" with 27 trials as a collaborator, "SWOG Cancer Research Network" with 24 trials as a collaborator and "Eastern Cooperative Oncology Group" with 18 trials as a collaborator. Other collaborators include 287 different institutions and companies that were collaborators in the rest 154 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNCIC Clinical Trials Group: 64NCIC Clinical Trials Group: 64Radiation TherapyOncology Group: 59Radiation TherapyOncology Group: 59Lawson HealthResearch Institute: 41Lawson HealthResearch Institute: 41National CancerInstitute (NCI): 40National CancerInstitute (NCI): 40Canadian Cancer TrialsGroup: 34Canadian Cancer TrialsGroup: 34Ontario ClinicalOncology Group(OCOG): 26Ontario ClinicalOncology Group(OCOG): 26Alliance for ClinicalTrials in Oncology: 21Alliance for ClinicalTrials in Oncology: 21University HealthNetwork, Toronto: 17University HealthNetwork, Toronto: 17Hoffmann-La Roche: 12Hoffmann-La Roche: 12Pfizer: 11Pfizer: 11

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 137National CancerInstitute (NCI): 137NRG Oncology: 33NRG Oncology: 33NCIC Clinical Trials Group: 27NCIC Clinical Trials Group: 27SWOG Cancer ResearchNetwork: 24SWOG Cancer ResearchNetwork: 24Eastern CooperativeOncology Group: 18Eastern CooperativeOncology Group: 18Canadian Cancer TrialsGroup: 15Canadian Cancer TrialsGroup: 15Cancer and LeukemiaGroup B: 15Cancer and LeukemiaGroup B: 15Radiation TherapyOncology Group: 12Radiation TherapyOncology Group: 12AstraZeneca: 11AstraZeneca: 11North Central CancerTreatment Group: 11North Central CancerTreatment Group: 11

Clinical Trials Conditions at London Regional Cancer Program


According to Clinical.Site data, the most researched conditions in "London Regional Cancer Program" are "Prostate Cancer" (50 trials), "Breast Cancer" (42 trials), "Lung Cancer" (21 trials), "Head and Neck Cancer" (20 trials) and "Colorectal Cancer" (17 trials). Many other conditions were trialed in "London Regional Cancer Program" in a lesser frequency.

Clinical Trials Intervention Types at London Regional Cancer Program


Most popular intervention types in "London Regional Cancer Program" are "Drug" (304 trials), "Radiation" (145 trials), "Other" (79 trials), "Procedure" (76 trials) and "Biological" (51 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (47 trials), "Laboratory Biomarker Analysis" (23 trials), "Placebo" (20 trials), "cisplatin" (20 trials) and "paclitaxel" (15 trials). Other intervention names were less common.

Clinical Trials Genders at London Regional Cancer Program


The vast majority of trials in "London Regional Cancer Program" are 288 trials for "All" genders, 86 trials for "Female" genders and 57 trials for "Male" genders.

Clinical Trials Status at London Regional Cancer Program


Currently, there are 119 active trials in "London Regional Cancer Program". 2 are not yet recruiting, 36 are recruiting, 80 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 270 completed trials in London Regional Cancer Program, 1 suspended trials, and 28 terminated clinical trials to date.
Out of the total trials that were conducted in London Regional Cancer Program, 32 "Phase 1" clinical trials were conducted, 179 "Phase 2" clinical trials and 196 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 46 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 196Phase 3: 196Phase 2: 179Phase 2: 179Not Applicable: 46Not Applicable: 46Phase 1: 32Phase 1: 32

Created with Highcharts 11.1.0Trials StatusCompleted: 270Completed: 270Active, not recruiting: 80Active, not recruiting: 80Recruiting: 36Recruiting: 36Terminated: 28Terminated: 28Unknown status: 8Unknown status: 8Withdrawn: 4Withdrawn: 4Not yet recruiting: 2Not yet recruiting: 2Enrolling by invitation: 1Enrolling by invitation: 1No longer available: 1No longer available: 1Suspended: 1Suspended: 1